Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-03, Stock:JNJ, The news for the past five days is as follows:
2021-05-26: NEWS1: German researchers tie cold viruses used to deliver COVID-19 vaccine to rare blood clot risk.NEWS2: Yesterday was first day dining activity exceeded pre-pandemic levels in the U.S.: OpenTable CEO.NEWS3: U.S. has ‘a false sense of security right now’ on COVID-19: Doctor.NEWS4: Biden to intensify investigation into COVID-19 origin.NEWS5: Belgium Stops JNJ COVID-19 Vaccine For Under 41 Years After One Death: Reuters.NEWS6: FDA May Not Review New COVID-19 Vaccine Emergency Use Requests.NEWS7: UPDATE 2-EU drug regulator reviewing woman's death in Belgium after getting J&J shot.NEWS8: EU drug regulator reviewing woman's death in Belgium after getting J&J shot.NEWS9: Doctor on Covid variants: ‘We’ve been fortunate that the vaccines have worked’.NEWS10: AbbVie's (ABBV) Venclyxto Gets EU Nod for First-Line AML.NEWS11: UPDATE 3-Belgium halts J&J COVID vaccine for under 41s after first EU death.NEWS12: Belgium says halts J&J COVID jab for under 41s after one dies.NEWS13: 2 Smart Stocks to Pick During a Market Correction.NEWS14: Scientists claim to have solved Covid vaccine blood-clot puzzle.
2021-05-27: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: Immunity to the coronavirus may persist for years, what it could mean for vaccination efforts.NEWS3: NJ lifting COVID-19 mandates is a ‘good step in the right direction’: Doctor.NEWS4: UPDATE 1-J&J unsure of meeting June COVID-19 vaccine supply target for EU.NEWS5: J&J unsure of meeting June COVID-19 vaccine supply target for EU -NOS.NEWS6: Top 10 Vaccine Companies in the World.NEWS7: EXPLAINER-How worried should we be about blood clots linked to AstraZeneca, J&J vaccines?.NEWS8: UPDATE 1-Ireland likely to miss June vaccine target as supplies slow.NEWS9: Ireland's June vaccine target in doubt as supplies slow again.NEWS10: UPDATE 4-India scraps local trials for COVID shots, says Pfizer vaccine could arrive by July.NEWS11: Correction: rare blood clots.
2021-05-28: NEWS1: Vir Biotechnology CEO on its covid-19 drug candidate winning FDA nod for emergency use.NEWS2: COVID-19 vaccine incentives include $1M, full college scholarships.NEWS3: This Just-Approved Amgen Drug Is the First to Hit a Hard Target in Cancer.NEWS4: Psychology of COVID-19 vaccine incentives ‘will only go so far’ : Doctor.NEWS5: Risk of new COVID-19 wave is ‘extremely high’: Doctor.NEWS6: Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJ.NEWS7: Microsoft reveals cyberattack, Nike splits from Neymar, Japan extends state of emergency.NEWS8: U.S. heads into holiday weekend with 51% of adults fully vaccinated and COVID cases down 35% from two weeks ago.NEWS9: Johnson & Johnson Covid-19 Vaccine Authorized for Use in U.K..NEWS10: Pharma Stock Roundup: JNJ Cancer Drug Gets FDA Nod, PFE, GSK, SNY Begin New Studies.NEWS11: Johnson & Johnson COVID-19 vaccine authorized for use in the U.K..NEWS12: UPDATE 3-Britain approves J&J COVID-19 vaccine, cuts order.NEWS13: Moderna and Pfizer are already developing COVID-19 vaccine boosters. Do we need a third shot?.NEWS14: COVID Vaccine Update: Where J&J, AstraZeneca, Novavax, and Sinovac Stand Now.NEWS15: UPDATE 1-Mexico authorizes J&J's COVID-19 vaccine for emergency use.NEWS16: UPDATE 1-U.S. FDA to allow Baltimore plant to resume J&J COVID-19 shot production -WSJ.NEWS17: UK approves use of Johnson & Johnson vaccine.
2021-06-01: NEWS1: UK reports zero covid-19 deaths for first time in nearly a year; MRNA seeks full FDA approval for vaccine.NEWS2: Supreme Court Rules Johnson & Johnson Must Pay $2.1 Billion in Baby Powder Lawsuit.NEWS3: Moderna seeks full FDA approval for its COVID-19 vaccine.NEWS4: Supreme Court Denies Johnson & Johnson's Challenge to Baby Powder Cancer Judgement.NEWS5: Johnson & Johnson Faces $2 Billion Payout Over Baby Powder Cancer Claims After Supreme Court Rejects Appeal.NEWS6: Supreme Court Won’t Hear Johnson & Johnson’s Appeal of a $2.1 Billion Verdict. What to Know..NEWS7: Supreme Court Won’t Consider Johnson & Johnson Challenge to Baby Powder Judgment.NEWS8: UPDATE 4-U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgment.NEWS9: J&J to Pay $2.1 Billion Talc Award as Top Court Nixes Appeal.NEWS10: Supreme Court rejects Johnson & Johnson’s appeal of $2 billion baby-powder verdict.NEWS11: CORRECTED-UPDATE 2-U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgment.NEWS12: U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgment.NEWS13: U.S. Supreme Court declines to hear J&J appeal over $2 billion baby powder judgment.NEWS14: Johnson & Johnson Slides as SCOTUS Passes on $2.1 Billion Talc Case Appeal.NEWS15: J&J Slips After U.S. Supreme Court Declines Review $2B Order.NEWS16: 3 Safest Robinhood Stocks You Can Buy Right Now.NEWS17: UPDATE 2-Foxconn, founder Gou apply to purchase BioNTech vaccines for Taiwan.NEWS18: Variants Get Greek Letter Names; Malaysia Lockdown: Virus Update.NEWS19: Cloudera, Tesla, Zoom Video, J&J - 5 Things You Must Know Tuesday.NEWS20: South Korea expands vaccination with J&J's COVID-19 shot offered by U.S..NEWS21: Tesla, Cloudera, Zoom Video, J&J - 5 Things You Must Know Tuesday.NEWS22: Johnson & Johnson to pay $2.1bn in talc cancer case after Supreme Court rejection.
2021-06-02: NEWS1: Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know.NEWS2: How health care in the U.S. may change after covid-19.NEWS3: ‘Vaccine confidence has gone up significantly’ in communities of color: Doctor.NEWS4: Employees suing companies requiring workers to get COVID-19 vaccine.NEWS5: New COVID-19 cases, deaths and hospitalizations keep falling in U.S., as vaccinations keep increasing.NEWS6: Immunovant (IMVT) Reports Narrower-Than-Expected Loss in Q4.NEWS7: J&J stock gains after Moody's says $2.5 billion payment for talc claims doesn't affect Aaa rating.NEWS8: Alkermes' (ALKS) Schizophrenia, Bipolar I Disorder Drug Approved.NEWS9: J&J (JNJ) to Pay $2.5B in Baby Powder Case on Appeal Rejection.NEWS10: Zero U.K. COVID-19 deaths recorded for first time since start of pandemic.NEWS11: Weary Seafarers Come Ashore in U.S. for J&J One-Dose Shots.NEWS12: Thirty Madison Vaults to Unicorn Status, Raises $140 Million.NEWS13: 15 Most Valuable Pharmaceutical Companies In The World.

Answer: Decrease